Department of Pharmacology, Kathmandu Medical College Teaching Hospital, Duwakot, Bhaktapur, Nepal.
Department of Community Medicine, Kathmandu Medical College Teaching Hospital, Duwakot, Bhaktapur, Nepal.
JNMA J Nepal Med Assoc. 2022 Jan 15;60(245):59-62. doi: 10.31729/jnma.7247.
Self-medication is a common practice worldwide. Major problems related to self-medication are wastage of resources, increased resistance of pathogens, adverse reactions, and prolonged suffering. This study aimed to find the prevalence of self-medication among medical students and staffs of a tertiary care centre during the COVID-19 pandemic.
A descriptive cross-sectional study was conducted among medical students and staffs of a tertiary care centre from 1st November to 30th November, 2021. Ethical clearance was taken from the Institutional Review Committee (Reference number: 2710202102). Convenience sampling was done to reach the sample size. Online questionnaires consisting of information on self-medication and socio-demographic characteristics were used. The data was transferred into an Excel spreadsheet and later was exported to Statistical Package for the Social Sciences version 20 for analysis. Point estimate at 95% confidence interval was calculated along with frequency and proportion for binary data.
Among 383 participants, the prevalence of self-medication during the pandemic was 193 (50.4%) (45.39-55.40 at 95% Confidence Interval). About half of the respondents 90 (50.3%) who self-medicated purchased the medicines directly from the pharmacy. The most consumed medicines were Paracetamol 128 (18.9%), Vitamin C 126 (18.6%), Zinc 86 (12.7%), Multivitamins 75 (11.1%), and Vitamin D 65 (9.6%) followed by Azithromycin 54 (8%), cough syrup 53 (7.8%) and Ibuprofen 46 (6.8%).
The prevalence of self-medication during the COVID-19 pandemic is lower compared to that of other developing countries. Paracetamol and Vitamin C are the most consumed drugs for self-medication and Azithromycin is the most used prescription-only drug for self-medication during the COVID-19 pandemic.
自我药疗在全球范围内较为常见。与自我药疗相关的主要问题包括资源浪费、病原体耐药性增加、不良反应和延长痛苦。本研究旨在了解在 COVID-19 大流行期间,一所三级保健中心的医学生和工作人员自我药疗的流行情况。
2021 年 11 月 1 日至 30 日,对一所三级保健中心的医学生和工作人员进行了一项描述性横断面研究。本研究获得了机构审查委员会的伦理批准(参考编号:2710202102)。采用方便抽样法达到样本量。使用包含自我药疗和社会人口学特征信息的在线问卷进行调查。将数据录入 Excel 电子表格,然后导出到统计软件包 20 版进行分析。计算了 95%置信区间的点估计值以及二进制数据的频率和比例。
在 383 名参与者中,大流行期间自我药疗的患病率为 193 例(50.4%)(95%置信区间为 45.39-55.40)。约一半的自我药疗者 90 人(50.3%)直接从药店购买药品。最常服用的药物是对乙酰氨基酚 128 例(18.9%)、维生素 C 126 例(18.6%)、锌 86 例(12.7%)、多种维生素 75 例(11.1%)和维生素 D 65 例(9.6%),其次是阿奇霉素 54 例(8%)、咳嗽糖浆 53 例(7.8%)和布洛芬 46 例(6.8%)。
与其他发展中国家相比,COVID-19 大流行期间自我药疗的患病率较低。对乙酰氨基酚和维生素 C 是自我药疗最常使用的药物,阿奇霉素是 COVID-19 大流行期间自我药疗最常使用的处方药物。